Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy

Preclinical evaluation demonstrates wild-type and high-risk PNPLA3 variant responses in human biomimetic liver microphysiology models, highlighting avenues for MASLD precision therapy.